Impact Biomedical IBO
NYSE IBO
$5.14 +0.35 (+7.31%)
At close: Nov 13, 2026 · 4:00 PM EST

Impact Biomedical (IBO) Non Operating Income (2022 - 2024)

Updated

Impact Biomedical (IBO) recorded Non Operating Income of -$227,000 in Q1 2024, compared with -$46,000 a year earlier.

Analysis

Impact Biomedical (IBO) Non Operating Income (2022 - 2024) Analysis & Trends

On a TTM basis, Impact Biomedical's Non Operating Income came in at -$485,000 as of Mar 31, 2024.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -202.00 Mn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 1.63 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -130.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Impact Biomedical 43.92 Mn 47.11 Mn 15,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -227,000.00
Sep 30, 2023 -99,000.00
Jun 30, 2023 -113,000.00
Mar 31, 2023 -46,000.00
Sep 30, 2022 -89,000.00
Jun 30, 2022 -49,000.00
API Access

Impact Biomedical Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=IBO&period=max&api_key=YOUR_API_KEY